Using AI to accelerate biotech is fast becoming standard practice, and companies offering services to deploy the tech quickly are seeing big uptake and new investment. Cradle is one of these, focused on protein design — and it just raised $73 million to build out its labs and team. Cradle appeared in 2022 as part of a wave of companies to exploring the use of language models in biotech. The company’s founder and CEO, Stef van Grieken, memorably referred to the strings of amino acids and bases as...